Description

n-[(R)-9-Methyl-4-Oxo-1-Phenyl-3,4,6,7-Tetrahydro[1,4]Diazepino[6,7,1-Hi]Indol-3-Yl]Isonicotinamide is a high-purity, complex heterocyclic organic compound with significant potential in advanced pharmaceutical research and development. Its intricate molecular architecture, featuring a fused diazepinoindole core, makes it a valuable key intermediate or building block for synthesizing novel active pharmaceutical ingredients (APIs). This compound is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents, particularly in neurological or oncological fields.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of novel drug candidates, especially those targeting complex biological pathways.
• Research Chemical: Used in academic and industrial research settings for studying structure-activity relationships (SAR) and developing new chemical entities (NCEs).
• Preclinical Development: Employed in the synthesis of compounds for pharmacological screening, toxicology studies, and early-stage drug development.
• Reference Standard: Can be utilized as an analytical standard for method development and quality control in API manufacturing processes.
• Chemical Biology Probe: Potential use in developing probes to investigate specific enzyme or receptor functions due to its unique heterocyclic structure.

Basic Information

Product Name	n-[(R)-9-Methyl-4-Oxo-1-Phenyl-3,4,6,7-Tetrahydro[1,4]Diazepino[6,7,1-Hi]Indol-3-Yl]Isonicotinamide
CAS No.	179024-48-7
Molecular Formula	C27H24N4O2
Molecular Weight	436.51 g/mol
Synonyms	(R)-N-(9-Methyl-4-oxo-1-phenyl-3,4,6,7-tetrahydro-1H-[1,4]diazepino[6,7,1-hi]indol-3-yl)isonicotinamide; 179024-48-7; UNII-9P5C9W3R0F; 9P5C9W3R0F; Diazepino[6,7,1-hi]indol-3-yl isonicotinamide derivative; Isonicotinamide, N-[(3R)-9-methyl-4-oxo-1-phenyl-3,4,6,7-tetrahydro-1H-[1,4]diazepino[6,7,1-hi]indol-3-yl]-
EINECS	Contact for details

Quality Control

Our n-[(R)-9-Methyl-4-Oxo-1-Phenyl-3,4,6,7-Tetrahydro[1,4]Diazepino[6,7,1-Hi]Indol-3-Yl]Isonicotinamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, chiral purity determination, and identity confirmation to ensure it meets the stringent requirements of pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting batch-specific results.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.